In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

Rua Bioscience Limited Balance Sheet Statement - Assets

As of 30 Jun 2022, The total current assets of Rua Bioscience Limited (NZX:RUA) was around $11,394,427 which consisted of $1,897,285 of Cash, $218,805 of Inventory and $543,799 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in NZD

Cash
$1.9M
Current assets
$11.39M
Total assets
$33.57M

The latest balance sheet of Rua Bioscience Limited also showed $6,640,056 of Property Plant Equipment and $10,448,082 of Good will. Also there were $5,016,035 of Intangible assets and $75,000 of Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $33,573,600.

Rua Bioscience Limited Balance Sheet Statement - Liabilities

RUA's latest annual results shows the balance sheet has $317,427 of Accounts Payable. Also there were no Short/Long term debt, no Long term debt, $3,953,429 of Other Current liabilities and $4,859,135 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$317.43k
Current liabilities
$4.86M
Total liabilities
$9.38M

As per the 30 Jun 2022's annual report of Rua Bioscience Limited, the total liabilities were $9,375,509.

RUA Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of Rua Bioscience Limited showed the total stock holder equity was $24,198,091 which consisted of $41,891,677 of Common stocks, $-17,835,272 of Retained earnings and $141,686 of Other stock holder equity.

RUA Balance Sheet Statement History

Following table shows the history of balance sheet for Rua Bioscience Limited (RUA).

30 Jun 2022 30 Jun 2021 30 Jun 2020 30 Jun 2019
Cash 1.9M 3.36M 3.94M 4.17M
Net Receivables 543.8k 604.24k 777.44k 301.17k
Inventory 218.81k - - -
Total Current Assets 11.39M 17.12M 4.82M 6.47M
Property Plant Equipment 6.64M 7.1M 5.91M 645.62k
Good Will 10.45M 4M 4M 4M
Intangible Assets 5.02M - - -
Other Assets 75k 2.63M 995.46k 13.69k
Deferred Long Term Asset Charges - 2.55M 798.21k 13.69k
Total Assets 33.57M 30.85M 15.73M 11.13M
Accounts Payable 317.43k 453.39k 512.01k 175.32k
Short/Long Term Debt - 10.76k 78.17k 43.33k
Other Current Liabilities 3.95M 56.78k 91.64k -
Long Term Debt - - 10.76k 49.85k
Other Liabilities 3.82M 31.91k 124.86k -
Total Current Liabilities 4.86M 1.18M 998.61k 469.79k
Total Liabilities 9.38M 2.02M 1.33M 621.56k
Common Stock 41.89M 37.42M 18.92M 12.48M
Retained Earnings -17.84M -9.2M -4.78M -1.97M
Treasury Stock 141.69k 614.77k 260.31k -
Other Stockholder Equity 141.69k 614.77k 260.31k -
Total Stockholder Equity 24.2M 28.83M 14.4M 10.51M
Net Tangible Assets 8.73M 24.83M 10.4M 6.51M

Rua Bioscience Limited (NZX:RUA) Balance Sheet Statement FAQ

1. How much Cash Rua Bioscience Limited has on their balance sheet?

As of 30 Jun 2022, Rua Bioscience Limited (NZX:RUA) has $1,897,285 of Cash.

2. What's the long term debt of Rua Bioscience Limited?

As per the latest Balance sheet of Rua Bioscience Limited (NZX:RUA), it has no Long term debt.

3. How much share holder equity does Rua Bioscience Limited has?

The Rua Bioscience Limited (NZX:RUA)'s balance sheet shows that it has $24,198,091 of Total stock holder equity.